drugset / Trial / NCT05873972

Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient

NCT05873972

Unknown 100 enrolled Fudan University
RandomizedParallel-groupOpen-labelTreatment

Summary

Establishment and validation of the deep learning model of Cetuximab efficacy in simultaneous RAS wild unresectable CRLM patients

Timeline

Start
2023-06-01
Primary completion
2024-06-01
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetuximab Monoclonal antibody